
MPACC Laboratory Manager
Publications
High-grade serous ovarian carcinoma organoids as models of chromosomal instability.
– Elife
(2023)
12,
e83867
(doi: 10.7554/elife.83867)
High-grade serous ovarian carcinoma organoids as models of chromosomal instability
(2022)
(doi: 10.1101/2022.09.01.506155)
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.
– EMBO Mol Med
(2022)
14,
e15729
(doi: 10.15252/emmm.202215729)
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models
(2022)
2022.01.15.476442
(doi: 10.1101/2022.01.15.476442)
Abstract 5879: Spatially-segmented single-cell transcriptomics by diffusional accessibility to a small-molecule dye
– Cancer Research
(2020)
80,
5879
Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer
– Annals of Oncology
(2019)
30,
vii10
(doi: 10.1093/annonc/mdz413.038)
Abstract 278: No cell left behind: Residual ovarian spheroids drive recurrence and are sensitive to the pro-oxidant elesclomol
– Cancer Research
(2016)
76,
278
(doi: 10.1158/1538-7445.AM2016-278)
Centrosomes - The Achilles' heel of high-grade serous ovarian cancer?
– MOLECULAR BIOLOGY OF THE CELL
(2015)
26,
Guidelines for the use of cell lines in biomedical research
– British Journal of Cancer
(2014)
111,
1021
(doi: 10.1038/bjc.2014.166)
Guidelines for the use of cell lines in biomedical research
– British Journal of Cancer
(2014)
111,
1021
(doi: 10.1038/bjc.2014.166)
- 1 of 3